Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 11301-11350 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05039450
A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)
PHASE2
Active, not recruiting
182 participants
Started: Jul 30, 2021 · Completed: May 31, 2025
1 condition
1 sponsor
49 locations
NCT04968249
Michigan Early Disease Progression Cohort
N/A
Active, not recruiting
200 participants
Started: Jul 30, 2021 · Completed: Mar 31, 2027
1 condition
1 sponsor
1 location
NCT04972825
AIR-B4: Mind the Gap
NA
Active, not recruiting
308 participants
Started: Jul 29, 2021 · Completed: Jan 5, 2026
2 conditions
7 sponsors
4 locations
NCT05055323
A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer
PHASE1
Active, not recruiting
20 participants
Started: Jul 29, 2021 · Completed: Dec 31, 2026
8 conditions
1 sponsor
1 location
NCT04883242
Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
PHASE2
Active, not recruiting
30 participants
Started: Jul 29, 2021 · Completed: Dec 31, 2031
2 conditions
2 sponsors
1 location
NCT07217184
Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Isatuximab in Participants With RRMM
PHASE1/PHASE2
Active, not recruiting
30 participants
Started: Jul 29, 2021 · Completed: Mar 11, 2027
1 condition
1 sponsor
19 locations
NCT06868667
Japan Expansion Cohort: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
PHASE3
Active, not recruiting
24 participants
Started: Jul 28, 2021 · Completed: Jun 19, 2026
1 condition
1 sponsor
16 locations
NCT05275101
Neural Mechanisms and Predictors of an Ultra-Brief Suicide Prevention Strategy
NA
Active, not recruiting
191 participants
Started: Jul 28, 2021 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT06868654
China Subpopulation: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
PHASE3
Active, not recruiting
72 participants
Started: Jul 28, 2021 · Completed: Jun 19, 2026
1 condition
1 sponsor
11 locations
NCT04945785
" SAVE Study (Switch AdVagraf® to Envarsus®) for Fast Metabolizers Kidney Transplant Recipients"
N/A
Active, not recruiting
226 participants
Started: Jul 28, 2021 · Completed: May 28, 2026
1 condition
1 sponsor
1 location
NCT04949256
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014)
PHASE3
Active, not recruiting
863 participants
Started: Jul 28, 2021 · Completed: Jan 31, 2027
1 condition
2 sponsors
198 locations
NCT04798781
Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma
PHASE2
Active, not recruiting
16 participants
Started: Jul 28, 2021 · Completed: Feb 14, 2026
2 conditions
2 sponsors
3 locations
NCT04401007
Erector Spinae Plane (ESP) Block Volunteer Study
NA
Active, not recruiting
24 participants
Started: Jul 28, 2021 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT04779970
COIN-B: COntrolled Interruption of Nucleos(t)Ide Analogue Treatment in Chronic Hepatitis B Infections
NA
Active, not recruiting
156 participants
Started: Jul 28, 2021 · Completed: Dec 31, 2025
1 condition
2 sponsors
26 locations
NCT04967365
Post-Intensive Care Syndrome - Pediatrics (PICS-p): Longitudinal Cohort Study
N/A
Active, not recruiting
755 participants
Started: Jul 27, 2021 · Completed: Jun 30, 2026
2 conditions
3 sponsors
30 locations
NCT05533099
REGENERA Implant in Localized Non-malignant Breast Lesions Treated by Excision or Lumpectomy - Long-term Follow-up
N/A
Active, not recruiting
14 participants
Started: Jul 27, 2021 · Completed: May 17, 2026
1 condition
2 sponsors
1 location
NCT04786093
Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC
PHASE2
Active, not recruiting
52 participants
Started: Jul 27, 2021 · Completed: May 31, 2027
1 condition
1 sponsor
1 location
NCT04923932
Savolitinib for Treating Gastric Cancer and Esophagogastric Junction Adenocarcinoma Patients
PHASE2
Active, not recruiting
75 participants
Started: Jul 27, 2021 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT04747613
Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
PHASE3
Active, not recruiting
208 participants
Started: Jul 27, 2021 · Completed: Oct 19, 2027
1 condition
1 sponsor
57 locations
NCT04635189
Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma
PHASE2
Active, not recruiting
28 participants
Started: Jul 27, 2021 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT04950894
Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation
NA
Active, not recruiting
150 participants
Started: Jul 27, 2021 · Completed: Oct 30, 2025
7 conditions
1 sponsor
20 locations
NCT04905277
Atenolol for the Prevention of Osteoporosis (APO)
PHASE2
Active, not recruiting
420 participants
Started: Jul 27, 2021 · Completed: Mar 31, 2026
1 condition
4 sponsors
3 locations
NCT05112913
Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine Between Different Workshops in Healthy Children Aged 3-17 Years
PHASE4
Active, not recruiting
2,520 participants
Started: Jul 27, 2021 · Completed: Dec 25, 2023
1 condition
1 sponsor
1 location
NCT04926922
PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia
N/A
Active, not recruiting
200 participants
Started: Jul 27, 2021 · Completed: Jun 7, 2026
2 conditions
1 sponsor
5 locations
NCT04982835
M6®-C Artificial Cervical Disc Two-Level IDE Pivotal Study
NA
Active, not recruiting
156 participants
Started: Jul 26, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
26 locations
NCT04570956
Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk
PHASE2
Active, not recruiting
65 participants
Started: Jul 26, 2021 · Completed: Dec 31, 2026
4 conditions
2 sponsors
3 locations
NCT05009329
A Study of JAB-21822 in Adult Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation in China
PHASE1/PHASE2
Active, not recruiting
311 participants
Started: Jul 26, 2021 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT04728607
Use of a Compression Device for Ring Removal: A Prospective Trial
NA
Active, not recruiting
50 participants
Started: Jul 26, 2021 · Completed: Nov 30, 2026
3 conditions
1 sponsor
1 location
NCT05057312
Promoting HPV Vaccination Among Young Adults in Texas
NA
Active, not recruiting
1,200 participants
Started: Jul 26, 2021 · Completed: Jul 31, 2026
1 condition
2 sponsors
1 location
NCT04910568
A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
PHASE1
Active, not recruiting
126 participants
Started: Jul 26, 2021 · Completed: Dec 10, 2025
1 condition
2 sponsors
27 locations
NCT04614168
Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes
NA
Active, not recruiting
17 participants
Started: Jul 26, 2021 · Completed: Dec 26, 2025
6 conditions
5 sponsors
1 location
NCT05064553
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
N/A
Active, not recruiting
2,990 participants
Started: Jul 26, 2021 · Completed: Dec 31, 2026
5 conditions
1 sponsor
76 locations
NCT05126446
the Aorta Arch Stent Graft System Combined With the Endovascular Needle System in Situ Fenestration
NA
Active, not recruiting
120 participants
Started: Jul 25, 2021 · Completed: Mar 30, 2028
1 condition
1 sponsor
1 location
NCT06629727
The Effect Of Virtual Reality Glasses On Pain And Anxiety During The Kidney Stone Lithotripsy Procedure
NA
Active, not recruiting
60 participants
Started: Jul 25, 2021 · Completed: Nov 10, 2024
3 conditions
1 sponsor
1 location
NCT04862286
Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977
PHASE3
Active, not recruiting
132 participants
Started: Jul 24, 2021 · Completed: Apr 30, 2028
1 condition
1 sponsor
41 locations
NCT04862429
Biopsy of Calcifications Under Contrast Enhancement Guide (BoCCE)
NA
Active, not recruiting
200 participants
Started: Jul 24, 2021 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT04906993
Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical Cancer
PHASE3
Active, not recruiting
443 participants
Started: Jul 23, 2021 · Completed: May 31, 2027
1 condition
1 sponsor
1 location
NCT04933721
Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies
PHASE3
Active, not recruiting
139 participants
Started: Jul 23, 2021 · Completed: Aug 31, 2031
2 conditions
1 sponsor
13 locations
NCT04830852
Pediatric COVID Outcomes Study (PECOS)
N/A
Active, not recruiting
5,000 participants
Started: Jul 23, 2021 · Completed: Jul 1, 2027
4 conditions
2 sponsors
2 locations
NCT05050643
High-Risk Veteran Initiative
NA
Active, not recruiting
17 participants
Started: Jul 23, 2021 · Completed: Dec 30, 2026
1 condition
7 sponsors
3 locations
NCT07073261
Prospective Multiethnic Validation of the Behçet's Syndrome Overall Damage Index (BODI)
N/A
Active, not recruiting
970 participants
Started: Jul 23, 2021 · Completed: Dec 30, 2027
1 condition
17 sponsors
1 location
NCT04918316
Initial Correction Keratoconus
NA
Active, not recruiting
32 participants
Started: Jul 23, 2021 · Completed: Sep 1, 2025
1 condition
1 sponsor
4 locations
NCT04580888
Emergency Echocardiography in Sepsis
NA
Active, not recruiting
312 participants
Started: Jul 23, 2021 · Completed: May 8, 2025
4 conditions
1 sponsor
10 locations
NCT04922307
Reduction of Allogenic Blood Transfusion in Locally Advanced Kidney Cancer
NA
Active, not recruiting
240 participants
Started: Jul 23, 2021 · Completed: Jun 15, 2027
1 condition
1 sponsor
3 locations
NCT04705818
Combining Epigenetic And Immune Therapy to Beat Cancer.
PHASE2
Active, not recruiting
173 participants
Started: Jul 23, 2021 · Completed: Dec 31, 2027
5 conditions
3 sponsors
3 locations
NCT04788615
Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS
PHASE3
Active, not recruiting
185 participants
Started: Jul 23, 2021 · Completed: Feb 13, 2026
1 condition
1 sponsor
41 locations
NCT04895735
MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer
PHASE2
Active, not recruiting
45 participants
Started: Jul 23, 2021 · Completed: Feb 28, 2028
4 conditions
1 sponsor
2 locations
NCT04530552
Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland
PHASE2
Active, not recruiting
34 participants
Started: Jul 23, 2021 · Completed: Jan 31, 2027
4 conditions
1 sponsor
5 locations
NCT04972513
Impact of E-cigarette Use on the Body
N/A
Active, not recruiting
182 participants
Started: Jul 22, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05913687
Automated Imaging Differentiation of Parkinsonism
N/A
Active, not recruiting
315 participants
Started: Jul 22, 2021 · Completed: Mar 31, 2026
3 conditions
22 sponsors
21 locations
Previous
1
More pages
224
225
226
227
228
229
230
More pages
431
Next